Brief: Getinge - Launch Of Vasoview Hemopro 3 To Occur In US During Q3 2024

Getinge publ AB

12/03/2024 07:13

March 12 (Reuters) - Getinge AB  GETIb.ST :
    * FDA 510(K) CLEARANCE OF VASOVIEW HEMOPRO 3, LATEST
ADDITION TO
MEDTECH COMPANY'S ENDOSCOPIC VESSEL HARVESTING (EVH) SOLUTIONS
    * IS PREPARING FOR PRODUCT LAUNCH OF VASOVIEW HEMOPRO 3 TO
OCCUR
IN THE US DURING Q3 2024, WHILE REGISTRATION IN ADDITIONAL KEY
MARKETS IS UNDERWAY


Further company coverage:  GETIb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))